Cepheid Infinity Kits/Tests
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the Cincinnati VA Medical Center, has published a Justification and Approval (J&A) for a sole-source contract to procure Cepheid Reagent kits for its existing GeneXpert instruments. This action, under the "Only One Responsible Source" authority, is for essential in vitro diagnostic substances. The estimated value is $674,775.70 per year for a period from April 15, 2026, to April 14, 2027.
Purpose & Scope
This J&A justifies the sole-source acquisition of various Cepheid Reagent kits, including MRSA NXG, C. diff, CT/NG, MTB, MVP, CARBA-R, DISPOSABLE SWAB, XPERT SWAB, and COLLECTION KIT A URINE PCR cartridges and collection kits. These reagents are critical for the microbiology laboratory at the Cincinnati VA Medical Center, ensuring the continued operation of their installed Cepheid GeneXpert instruments. The reagents are exclusively available from the Original Equipment Manufacturer (OEM), Cepheid Inc.
Contract Details
- Type: Firm Fixed Price (Sole-Source Justification)
- Estimated Value: $674,775.70 per year
- Period of Performance: April 15, 2026 - April 14, 2027
- Set-Aside: Not applicable. This is a sole-source justification due to the exclusive availability of the required reagents from Cepheid Inc.
Justification & Market Research
The sole-source determination is based on the "Only One Responsible Source" authority (41 USC §3304(a)(1)). Market research indicated that no other vendors could satisfy the agency's requirements, and neither the VA Rule of Two nor the SBA Rule of Two could be met. A Notice of Intent to Sole Source was posted on GPE on April 1, 2026, with a response date of April 8, 2026, and no responses were received. The anticipated cost was determined to be fair and reasonable through market trend review. The agency plans to continue market research for future acquisitions.
Contact Information
- Primary Contact: Rachel MacRae
- Email: rachel.macrae@va.gov